AFC-HD AMS Life Science Co.,Ltd.【JP:2927】Cash flow
Market cap
¥12.7B
P/E ratio
8.5x
| 2014/08 | 2015/08 | 2016/08 | 2017/08 | 2018/08 | 2019/08 | 2020/08 | 2021/08 | 2022/08 | 2023/08 | 2024/08 | 2025/08 | |
| Depreciation & amortization | 508 | 432 | 396 | 383 | 436 | 473 | 509 | 612 | 854 | 824 | 863 | 1,090 |
| Cash from operations | 893 | 857 | 854 | 526 | 1,222 | 1,132 | 1,299 | 2,583 | 1,492 | 901 | 1,489 | 1,854 |
| Capital expenditures | -229 | -258 | -163 | -852 | -549 | -547 | -381 | -492 | -958 | -1,975 | -3,407 | -3,606 |
| Cash from investing | -260 | -86 | -220 | -847 | -850 | -202 | -459 | -275 | -1,611 | -1,982 | -2,693 | -3,395 |
| Payments for dividends | -177 | -119 | -180 | -181 | -181 | -280 | -350 | -313 | -422 | -385 | -419 | -434 |
| Repurchases of common stock | - | -0 | - | -0 | - | - | -0 | -153 | -289 | -80 | - | -13 |
| Proceeds from issuance of term debt, net | - | 800 | - | 300 | 1,622 | - | 700 | 9,500 | 635 | 1,685 | 1,558 | 1,357 |
| Repayments of term debt | -682 | -652 | -532 | -521 | -2,021 | -321 | -831 | -5,581 | -1,035 | -380 | -128 | -1,176 |
| Cash from financing | -1,068 | -907 | -987 | -46 | 280 | -547 | -575 | 2,185 | 1,693 | 1,881 | 1,977 | 667 |
| Free cash flow | ||||||||||||
| FCF margin (%) |